Organ-Specific Tumor Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-Based Chemotherapy

To evaluate the organ-specific therapeutic effect of pembrolizumab after the failure of platinum-based chemotherapy for advanced urothelial carcinoma (UC). Patients with advanced UC who received pembrolizumab after the failure of platinum-based chemotherapy and who had measurable disease were retros...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	OncoTargets and therapy 2021-01, Vol.14, p.1981-1988
Hauptverfasser:	Furubayashi, Nobuki, Negishi, Takahito, Sakamoto, Naotaka, Shimokawa, Hozumi, Morokuma, Futoshi, Song, Yoohyun, Hori, Yoshifumi, Tomoda, Toshihisa, Tokuda, Noriaki, Seki, Narihito, Kuroiwa, Kentaro, Nakamura, Motonobu
Format:	Artikel
Sprache:	eng
Schlagworte:	Atrophy Bladder Bladder cancer Cancer Carcinoma Chemotherapy Disease control Health aspects Immunotherapy Liver Lymph nodes Lymphatic system Melanoma Metastases Metastasis Monoclonal antibodies Original Research Patients Pembrolizumab Platinum Response rates Solid tumors Targeted cancer therapy Urothelial carcinoma
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!